MOSCOW, January 22. /TASS/. The Russian Direct Investment Fund (RDIF) has entered into a contract on supply of the Russian anti-coronavirus vaccine Sputnik V with the Hungarian side, Minister of Healthcare Mikhail Murashko said following a meeting with Hungarian Minister of Foreign Affairs and Trade Peter Szijjarto on Friday.
"The Russian Direct Investment Fund and the Hungarian side have signed a contract on supply of vaccines to Hungary," Murashko said.
Hungarian experts visited the Gamaleya National Research Institute of Epidemiology and Microbiology and reviewed the clinical trials of the vaccine being carried out in Russia, the minister said, adding that "new horizons" for cooperation between the two countries are opening up.
"I would like to note that many countries actively approve the use of the Russian vaccine Sputnik V today, particularly an active cooperation with the World Health Organization is underway," Murashko said.
Hungarian Minister of Foreign Affairs and Trade Peter Szijjarto said that the Russian vaccine will be supplied to the country in three stages.
The Hungarian online media outlet Index reported earlier this week that the National Institute of Pharmacy and Nutrition had completed examining the documentation on the Russian vaccine Sputnik V and approved its use.
Meanwhile the Russian Direct Investment Fund confirmed on Thursday that the National Institute of Pharmacy and Nutrition of Hungary had approved Russia’s Sputnik V.
Hungary became the first EU country in November 2020 where Sputnik V samples were supplied for trials.